1a1c:B (THR157) to (LYS235) C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(- (CH2)3-CYCLOPENTYL)) | COMPLEX (TRANSFERASE/PEPTIDE)
1a81:A (THR21) to (GLU95) CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM | COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX
1a81:C (SER174) to (LYS247) CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM | COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX
1a81:I (SER174) to (LYS247) CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM | COMPLEX (TRANSFERASE-PEPTIDE), SYK, KINASE, SH2 DOMAIN, ITAM, COMPLEX (TRANSFERASE-PEPTIDE) COMPLEX
4gwf:A (SER118) to (PRO201) CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION | ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE
4gwf:B (SER118) to (ASN200) CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION | ALPHA/BETA PROTEINS, SH2 DOMAIN, PHOSPHATASE DOMAIN, TYROSINE PHOSPHATASE SHP-2, HYDROLASE
2awf:A (GLY6) to (ASP130) STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 G1 | LIGASE, UBL CONJUGATION PATHWAY, UBIQUITIN-CONJUGATING ENZYME, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC
2oq1:A (SER18) to (ASP92) TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE | TANDEM SH2 DOMAINS, ZAP-70, TYROSINE KINASE, TRANSFERASE
1aou:F (GLY13) to (ARG92) NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES | SH2 DOMAIN, SIGNAL TRANSDUCTION, PEPTIDE COMPLEX, COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN)
2b3o:A (SER10) to (GLN82) CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1 | PROTEIN TYROSINE PHOSPHATASE, SHP-1, SIGNALING, HYDROLASE
1nrv:B (SER441) to (ASN519) CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10 | DIMER, SIGNALING PROTEIN
2ozo:A (SER16) to (ASP90) AUTOINHIBITED INTACT HUMAN ZAP-70 | INACTIVE ZAP-70, TANDEM SH2, AUTOINHIBITION, ITAM, HYDROGEN BONDING NETWORK, TCR SIGNALING, TRANSFERASE
1blj:A (SER20) to (GLY99) NMR ENSEMBLE OF BLK SH2 DOMAIN, 20 STRUCTURES | SIGNAL TRANSDUCTION, TYROSINE KINASE, TRANSFERASE, PHOSPHOTRANSFERASE, PHOSPHORYLATION
1blk:A (SER20) to (LYS98) NMR ENSEMBLE OF BLK SH2 DOMAIN USING CHEMICAL SHIFT REFINEMENT, 20 STRUCTURES | SIGNAL TRANSDUCTION, TYROSINE KINASE, TRANSFERASE, PHOSPHOTRANSFERASE, PHOSPHORYLATION
2ple:A (THR17) to (HIS87) NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE | PHOSPHORIC DIESTER HYDROLASE
2c0i:A (SER129) to (GLY208) SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 | TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN
2c0i:B (SER129) to (LYS207) SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 | TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN
2c0o:A (SER129) to (GLY208) SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 | TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN
2c0o:B (SER129) to (LYS207) SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 | TYROSINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, PHOSPHORYLATION, SH2 DOMAIN, SH3 DOMAIN
1opk:A (SER152) to (VAL224) STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE | TRANSFERASE
1opl:A (SER152) to (VAL224) STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE | TRANSFERASE
1opl:B (SER152) to (VAL224) STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE | TRANSFERASE
3fsh:A (HIS0) to (ALA128) CRYSTAL STRUCTURE OF THE UBIQUITIN CONJUGATING ENZYME UBE2G2 BOUND TO THE G2BR DOMAIN OF UBIQUITIN LIGASE GP78 | PROTEIN-PEPTIDE COMPLEX, LIGASE, UBL CONJUGATION PATHWAY, ALTERNATIVE SPLICING, ENDOPLASMIC RETICULUM, MEMBRANE, METAL-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, ZINC, ZINC-FINGER
1d1z:A (SER1012) to (PHE1087) CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP | SH2 DOMAINS, GENE REGULATION
1d1z:D (SER4012) to (PHE4087) CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP | SH2 DOMAINS, GENE REGULATION
1d4t:A (SER12) to (GLN88) CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE | SH2 DOMAIN, TYROSINE KINASE, SIGNAL TRANSDUCTION, PEPTIDE RECOGNITION, SIGNALING PROTEIN
1d4w:B (SER12) to (GLN88) CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE | SH2 DOMAIN, PHOSPHOTYROSINE RECOGNIITON, PEPTIDE RECOGNITION, SIGNAL TRANSDUCTION, LYMPHOPROLIFERATIVE DISEASE, SIGNALING PROTEIN
2cia:A (THR291) to (LYS361) HUMAN NCK2 SH2-DOMAIN IN COMPLEX WITH A DECAPHOSPHOPEPTIDE FROM TRANSLOCATED INTIMIN RECEPTOR (TIR) OF EPEC | SH2-DOMAIN, SH3 DOMAIN, PHOSPHORYLATION, BINDING SPECIFICITY
2ci9:A (THR288) to (LYS357) NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR | PROTEIN-BINDING, SH2-DOMAIN/COMPLEX
2ci9:B (THR288) to (LYS357) NCK1 SH2-DOMAIN IN COMPLEX WITH A DODECAPHOSPHOPEPTIDE FROM EPEC PROTEIN TIR | PROTEIN-BINDING, SH2-DOMAIN/COMPLEX
2cs0:A (SER24) to (GLN94) SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN HSH2D PROTEIN | ALX, FLJ14886, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN
2cyx:B (GLY-4) to (ALA128) STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 G2 (UBE2G2/UBC7) | UBIQUITIN-CONJUGATING ENZYME (E2), UBL CONJUGATION PATHWAY, LIGASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI
2dcr:A (PRO24) to (GLN92) FULLY AUTOMATED SOLUTION STRUCTURE DETERMINATION OF THE FES SH2 DOMAIN | SH2 DOMAIN, FES, FELINE SARCOMA ONCOGENE, FULLY AUTOMATED STRUCTURE DETERMINATION, FLYA ALGORITHM, TRANSFERASE
2dlz:A (GLU24) to (SER96) SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTEIN VAV-2 | RHO FAMILY GUANINE NUCLEOTIDE EXCHANGE FACTOR, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN
2rsy:A (THR88) to (ASP159) SOLUTION STRUCTURE OF THE SH2 DOMAIN OF CSK IN COMPLEX WITH A PHOSPHOPEPTIDE FROM CBP | SH2 DOMAIN, CSK, CBP, SOLUTION STRUCTURE, TRANSFERASE-SIGNALING PROTEIN COMPLEX
2rvf:A (SER14) to (HIS84) SOLUTION NMR STRUCTURE OF MONOSIGA BREVICOLLIS CRK/CRKL HOMOLOG (CRKA1) SH2 DOMAIN | SIGNAL TRANSDUCTION, PHOSPHOTYROSINE-BINDING DOMAIN, SIGNALING PROTEIN
2shp:A (THR12) to (HIS84) TYROSINE PHOSPHATASE SHP-2 | TYROSINE PHOSPHATASE, INSULIN SIGNALING, SH2 PROTEIN
2shp:B (THR12) to (HIS84) TYROSINE PHOSPHATASE SHP-2 | TYROSINE PHOSPHATASE, INSULIN SIGNALING, SH2 PROTEIN
3h8k:A (GLY3) to (ALA128) CRYSTAL STRUCTURE OF UBE2G2 COMPLXED WITH THE G2BR DOMAIN OF GP78 AT 1.8-A RESOLUTION | ALPHA BETA, ALL ALPHA, LIGASE, UBL CONJUGATION PATHWAY, ENDOPLASMIC RETICULUM, MEMBRANE, METAL-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSMEMBRANE, ZINC-FINGER
1fbz:A (SER11) to (ALA90) STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY | SH2 DOMAIN, NONPEPTIDE INHIBITOR, TRANSFERASE
2eu0:A (SER17) to (ASN97) THE NMR ENSEMBLE STRUCTURE OF THE ITK SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE | CIS/TRANS ISOMERIZATION, INTERLEUKIN-2 TYROSINE KINASE, ITK, T-CELL SPECIFIC KINASE, TSK, SRC HOMOLOGY 2, SH2, PROLINE, PHOSPHOTYROSINE BINDING, TRANSFERASE
4k44:A (THR674) to (HIS744) AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES | SH2 DOMAIN, HYDROLASE, PLC-GAMMA1
4k44:B (THR674) to (HIS744) AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES | SH2 DOMAIN, HYDROLASE, PLC-GAMMA1
4k45:A (THR674) to (HIS744) AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES | SH2 DOMAIN, PLC-GAMMA1, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2eyy:A (SER19) to (LYS105) CT10-REGULATED KINASE ISOFORM I | SH2, SH3, SIGNALING PROTEIN
2eyz:A (SER19) to (HIS107) CT10-REGULATED KINASE ISOFORM II | SH2, SH3, SIGNALING PROTEIN
2fci:A (GLN20) to (HIS87) STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE | SH2 DOMAIN, PHOSPHOPEPTIDE, SYK KINASE, PLCGAMMA, PLCC, HYDROLASE
4z32:A (MET406) to (TYR481) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
4z32:B (MET406) to (TYR481) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
4z32:C (MET406) to (TYR481) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
4z32:E (MET406) to (TYR481) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
4z32:F (MET406) to (TYR481) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
4z32:H (MET406) to (CYS480) CRYSTAL STRUCTURE OF THE FERM-SH2 DOMAINS OF JAK2 | JAK-STAT, FERM DOMAIN, SH2 DOMAIN, CYTOKINE RECEPTOR, TRANSFERASE
3uyo:A (SER152) to (SER222) CRYSTAL STRUCTURE OF MONOBODY SH13/ABL1 SH2 DOMAIN COMPLEX | ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX
1shd:A (THR157) to (HIS236) PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS | COMPLEX(TRANSFERASE-PEPTIDE), COMPLEX(TRANSFERASE-PEPTIDE) COMPLEX
1spr:B (THR11) to (HIS90) BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS | TRANSFERASE(PHOSPHOTRANSFERASE)
2hdv:A (SER533) to (ARG605) CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF THE ADAPTER PROTEIN SH2-B | SH2, ADAPTER PROTEIN, SIGNALING PROTEIN
2hdx:A (LEU535) to (ARG605) CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE | SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN
2hdx:B (SER533) to (ARG605) CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE | SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN
2hdx:D (SER533) to (ARG605) CRYSTAL STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF SH2-B IN COMPLEX WITH JAK2 PTYR813 PHOSPHOPEPTIDE | SH2, JAK2, PHOSPHOTYROSINE, ADAPTER PROTEIN, SIGNALING PROTEIN
3von:C (PRO5) to (ALA114) CRYSTALSTRUCTURE OF THE UBIQUITIN PROTEASE | UBIQUITIN PROTEASE, HYDROLASE-LIGASE COMPLEX
3vrz:A (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vrz:B (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-BENZYLUREA | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs1:B (SER155) to (TYR231) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]- 3-PHENYLUREA | TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs2:A (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[2,3-D]PYRIMIDIN-4-AMINE | TYROSINE KINASE, SRC-FAMILY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs2:B (SER155) to (LYS232) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H- PYRROLO[2,3-D]PYRIMIDIN-4-AMINE | TYROSINE KINASE, SRC-FAMILY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs4:B (SER155) to (LYS232) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs5:A (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs7:A (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H- PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2hmh:A (GLY53) to (MET128) CRYSTAL STRUCTURE OF SOCS3 IN COMPLEX WITH GP130(PTYR757) PHOSPHOPEPTIDE. | SOCS3, GP130, PTYR, PEPTIDE COMPLEX, CYTOKINE REGULATOR
4lue:B (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3- D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002) | COCRYSTALLIZATION, SKF86002, FLUORESCENCE, INHIBITOR SCREENING, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2xp1:A (ASN799) to (SER863) STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6 | TRANSCRIPTION, IWS1, HISTONE CHAPERONE, MRNA EXPORT
2xp1:A (SER885) to (LYS953) STRUCTURE OF THE TANDEM SH2 DOMAINS FROM ANTONOSPORA LOCUSTAE TRANSCRIPTION ELONGATION FACTOR SPT6 | TRANSCRIPTION, IWS1, HISTONE CHAPERONE, MRNA EXPORT
5bo4:A (THR54) to (LYS134) STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS | SIGNALING PROTEIN, UBIQUITIN LIGASE, SUPPRESSOR OF CYTOKINE SIGNALLING
5bo4:M (LEU62) to (LYS134) STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B FROM DMSO-TREATED CRYSTALS | SIGNALING PROTEIN, UBIQUITIN LIGASE, SUPPRESSOR OF CYTOKINE SIGNALLING
2jyq:A (ARG12) to (HIS90) NMR STRUCTURE OF THE APO V-SRC SH2 DOMAIN | PROTEIN, SRC, SH2, SRC HOMOLOGY 2, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, ONCOGENE, PHOSPHOPROTEIN, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE
1k9a:A (THR88) to (ASP159) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION | CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE
1k9a:B (THR88) to (ASP159) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION | CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE
1k9a:C (GLU90) to (ASP159) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION | CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE
1k9a:D (ARG89) to (THR157) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION | CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE
1k9a:E (ARG89) to (ASP159) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION | CARBOXYL-TERMINAL SRC KINASE, COOH-TERMINAL SRC KINASE, CSK, SRC, SFK, SIGNAL TRANSDUCTION, SH2, SH3, SRC HOMOLOGY, TYROSINE KINASE, CYTOPLASMIC TYROSINE KINASE, CBP, ONCOGENE, CANCER, TRANSFERASE
1ka6:A (SER12) to (GLN88) SAP/SH2D1A BOUND TO PEPTIDE N-PY | SH2 DOMAIN, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM
1kc2:A (THR156) to (HIS235) STRUCTURE OF THE TRIPLE (LYS(BETA)D3ALA, ASP(BETA)C8ALA, ASPCD2ALA) MUTANT OF THE SRC SH2 DOMAIN BOUND TO THE PQPYEEIPI PEPTIDE | SH2 DOMAIN, PHOSPHOTYROSINE, TRANSFERASE
2l3t:A (ASN14) to (SER104) SOLUTION STRUCTURE OF TANDEM SH2 DOMAIN FROM SPT6 | SH2, SPT6, TRANSCRIPTION
2l3t:A (LYS112) to (HIS195) SOLUTION STRUCTURE OF TANDEM SH2 DOMAIN FROM SPT6 | SH2, SPT6, TRANSCRIPTION
2lxp:A (GLY3) to (ALA128) NMR STRUCTURE OF TWO DOMAINS IN UBIQUITIN LIGASE GP78, RING AND G2BR, BOUND TO ITS CONJUGATING ENZYME UBE2G | RING DOMAIN, UBIQUITIN, LIGASE
1x27:D (SER133) to (ALA212) CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P130CAS | LCK-CAS COMPLEX, LCK PHOSPHO-PEPTIDE COMPLEX, HIGH AFFINITY LCK-CAS COMPLEX, SIGNALING PROTEIN
2mk2:A (SER19) to (PRO97) SOLUTION NMR STRUCTURE OF N-TERMINAL DOMAIN (SH2 DOMAIN) OF HUMAN INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE PROTEIN 1 (INPPL1) (FRAGMENT 20-117), NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR9134A | STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, HYDROLASE
4nwf:A (SER118) to (PRO201) CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION | HYDROLASE
4nwf:B (SER118) to (PRO201) CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION | HYDROLASE
4nwg:B (GLU121) to (PRO201) CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION | HYDROLASE
2mqi:A (GLY155) to (ARG234) HUMAN FYN SH2 FREE STATE | SH2 DOMAIN, FYN KINASE, SRC KINASE, TRANSFERASE
2mrk:A (LYS157) to (ARG234) FYN SH2 DOMAIN IN COMPLEX WITH THE NATURAL INHIBITORY PHOSPHOTYROSINE PEPTIDE | PHOSPHORYLATED PEPTIDE, FYN KINASE, SH2 DOMAIN, SRC KINASE, TRANSFERASE
3k2m:A (SER152) to (VAL224) CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX | ENGINEERED BINDING PROTEIN, ANTIBODY MIMIC, PROTEIN-PROTEIN COMPLEX, SH2 DOMAIN, ATP-BINDING, PHOSPHOPROTEIN, TYROSINE-PROTEIN KINASE, SIGNALING PROTEIN, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX
4ohd:A (THR12) to (TYR81) LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT | SH2 DOMAIN, PHOSPHATASE DOMAIN, HYDROLASE
1mil:A (SER15) to (ASP82) TRANSFORMING PROTEIN | SH2 DOMAIN, PHOSPHORYLATION, COLLAGEN, GROWTH REGULATION, TRANSFORMING PROTEIN, ALTERNATIVE INITIATION
1y57:A (THR154) to (HIS233) STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR | KINASE STRUCTURE, SH3, SH2, TRANSFERASE
4po6:A (GLU457) to (GLN534) CRYSTAL STRUCTURE OF THE HUMAN TYK2 FERM AND SH2 DOMAINS WITH AN IFNAR1 INTRACELLULAR PEPTIDE | FERM, SH2, KINASE, RECEPTOR, CYTOKINE, INTRACELLULAR, TRANSFERASE
5eg3:B (THR674) to (LYS743) CRYSTAL STRUCURE OF THE ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH THE CSH2 DOMAIN OF PHOSPHOLIPASE C GAMMA (PLCGAMMA) | SIGNALING COMPLEX, TYROSINE KINASE DOMAIN, SH2 DOMAIN, RECRUITMENT, PHOSPHORYLATION, TRANSFERASE-HYDROLASE COMPLEX
3maz:A (SER183) to (ARG261) CRYSTAL STRUCTURE OF THE HUMAN BRDG1/STAP-1 SH2 DOMAIN IN COMPLEX WITH THE NTAL PTYR136 PEPTIDE | MODULAR DOMAIN, PHOSPHOTYROSINE, SPECIFICITY, CYTOPLASM, PHOSPHOPROTEIN, SH2 DOMAIN, SIGNALING PROTEIN
3bkb:A (ARG467) to (GLN534) CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES) | FES, V-FES, FUJINAMI, AVIAN SARCOMA, VIRAL, ONCOGENE, FELINE SARCOMA VIRUS, SGC, STRUCTURAL GENOMICS CONSORTIUM, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE
3nhn:A (SER154) to (LYS232) CRYSTAL STRUCTURE OF THE SRC-FAMILY KINASE HCK SH3-SH2-LINKER REGULATORY REGION | HCK, SH3-SH2-LINKER, SRC FAMILY KINASE, SFK, TRANSFERASE
4u5w:B (SER154) to (GLY233) CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WITH THE SRC FAMILY KINASE HCK SH3-SH2 TANDEM REGULATORY DOMAINS | HCK, SH3-SH2 REGULATORY DOMAINS, SH3, SH2, SRC FAMILY KINASE, SFK, HIV-1, NEF, VIRUS, PROTEIN-PROTEIN COMPLEX, NEF-HCK COMPLEX, VIRAL PROTEIN-TRANSFERASE COMPLEX
4u5w:D (SER154) to (GLY233) CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WITH THE SRC FAMILY KINASE HCK SH3-SH2 TANDEM REGULATORY DOMAINS | HCK, SH3-SH2 REGULATORY DOMAINS, SH3, SH2, SRC FAMILY KINASE, SFK, HIV-1, NEF, VIRUS, PROTEIN-PROTEIN COMPLEX, NEF-HCK COMPLEX, VIRAL PROTEIN-TRANSFERASE COMPLEX
5i6v:A (THR12) to (HIS84) STRUCTURE OF F285S, A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2 | SHP2, CANCER-ASSOCIATED MUTATION, INHIBITORS, HYDROLASE
4e93:A (PRO466) to (GLN534) CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V- FES)IN COMPLEX WITH TAE684 | V-FES, FUJINAMI, AVIAN SARCOMA, VIRAL, ONCOGENE, FELINE SARCOMA VIRUS, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3psj:A (GLY1264) to (SER1353) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM SE-SPT6 (1247-1451) | TANDEM SH2, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psj:A (LYS1361) to (SER1440) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM SE-SPT6 (1247-1451) | TANDEM SH2, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:A (GLY1264) to (SER1353) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:A (THR1360) to (SER1440) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:B (LYS1361) to (SER1440) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:C (ARG1265) to (ILE1336) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:C (THR1360) to (GLY1433) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
3psk:D (ARG1265) to (SER1353) CRYSTAL STRUCTURE OF THE SPT6 TANDEM SH2 DOMAIN FROM SACCHAROMYCES CEREVISIAE, FORM NATIVE SPT6 (1247-1451) | TANDEM SH2 DOMAIN, TRANSCRIPTION ELONGATION, NUCLEUS, TRANSCRIPTION
4ey0:A (THR674) to (HIS744) STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1 | SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE
4ey0:B (THR674) to (HIS744) STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1 | SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE
4ey0:C (THR674) to (HIS744) STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1 | SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE
4ey0:D (THR674) to (HIS744) STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1 | SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE
4f5a:A (THR157) to (HIS236) TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHATE ION | SH2 DOMAIN, CELL SIGNALLING, PHOSPHOTYROSINE, PROTEIN BINDING
4f5b:A (THR157) to (HIS236) TRIPLE MUTANT SRC SH2 DOMAIN BOUND TO PHOSPHOTYROSINE | SH2 DOMAIN, CELL SIGNALLING, PHOSPHOTYROSINE, PROTEIN BINDING
4fbn:A (THR674) to (PRO745) INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULATORY REGION AND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KEY ROLES OF SH2 DOMAINS | SH2 DOMAIN, PLCGAMMA SPECIFIC ARRAY, INTERACTION DOMAIN, FIBROBLAST GROWTH FACTOR RECEPTOR 1, HYDROLASE
3qwx:X (SER20) to (LYS100) CED-2 1-174 | CELL ENGULFMENT, SIGNALING PROTEIN
3qwy:B (SER20) to (VAL103) CED-2 | CELL ENGULFMENT, SIGNALING PROTEIN
5l04:A (GLN455) to (LYS527) STRUCTURE OF INTERFERON LAMBDA 1 RECEPTOR WITH HUMAN KINASE JAK1 | COMPLEX OF JAK1 AND INTERFERON LAMBDA 1, JAK KINASE, INTRACELLULAR DOMAIN OF IFNLR1, FERM DOMAIN, SH2-LIKE DOMAIN, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
1bfi:A (ASN17) to (THR88) SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, 30 STRUCTURES | SH2 DOMAIN, P85ALPHA, PI 3-KINASE, NMR, C TERMINAL SH2 DOMAIN
2c0t:B (SER129) to (GLY208) SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359 | TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, SH2 DOMAIN, SH3 DOMAIN
4jeg:A (SER118) to (ASN200) CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX | ENGINEERED BINDING PROTEIN, SHP2 SH2-MONOBODY COMPLEX, PHOSPHATASE, PHOSPHOTYROSINE BINDING, PHOSPHORYLATION, SIGNALING PROTEIN-PROTEIN BINDING COMPLEX
3gxx:A (GLY18) to (ILE98) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxx:B (GLY18) to (ARG99) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxx:C (LYS19) to (GLU103) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxx:D (LYS19) to (GLU103) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM B | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxw:A (GLY18) to (LEU100) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxw:B (GLY18) to (LEU100) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxw:C (GLY18) to (LEU101) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
3gxw:D (GLY18) to (ASN102) STRUCTURE OF THE SH2 DOMAIN OF THE CANDIDA GLABRATA TRANSCRIPTION ELONGATION FACTOR SPT6, CRYSTAL FORM A | SH2-FOLD, THREE STRANDED ANTI-PARALLEL BETA SHEET, N- TERMINAL ALPHA HELIX, C-TERMINAL ALPHA HELIX, NUCLEUS, SH2 DOMAIN, TRANSCRIPTION, TRANSCRIPTION REGULATION
2dvj:A (SER19) to (TYR104) PHOSPHORYLATED CRK-II | SH3, SH2, SIGNAL TRANSDUCTION, ADAPTER MOLECULE, SIGNALING PROTEIN
2eyv:A (ARG20) to (TYR104) SH2 DOMAIN OF CT10-REGULATED KINASE | SH2, SIGNALING PROTEIN
2gsb:A (LEU31) to (GLU96) SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN OF HUMAN RAS GTPASE-ACTIVATING PROTEIN 1 | GTPASE-ACTIVATING PROTEIN, GAP, RAS P21 PROTEIN ACTIVATOR, P120GAP, RASGAP, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN
2h8h:A (THR154) to (HIS233) SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR | SRC KINASE, TRANSFERASE
3vry:B (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL- CYCLOPENTANE | TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3vs0:B (SER155) to (GLY234) CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2mrj:A (LEU154) to (SER232) STRUCTURE OF FYN PROTEIN SH2 BOUND | FYN KINASE, SRC KINASE, SH2 DOMAIN, TRANSFERASE
2ysx:A (THR18) to (LYS94) SOLUTION STRUCTURE OF THE HUMAN SHIP SH2 DOMAIN | SH2 DOMAIN, PHOSPHOTYROSINE BINDING DOMAIN, PROTEIN TYROSINE KINASE, SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN
4dgx:A (THR12) to (GLU83) LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT | HYDROLASE
4eih:A (LEU187) to (SER249) CRYSTAL STRUCTURE OF ARG SH2 DOMAIN | SH2 DOMAIN, PROTEIN/PROTEIN INTERACTION, PHOSPHOTYROSINE, PHOSPHOPEPTIDE, TRANSFERASE
4fl2:A (SER174) to (ALA248) STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH | TRANSFERASE, PROTEIN KINASE
4fl3:A (SER174) to (ALA248) STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH | TRANSFERASE, PROTEIN KINASE